These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36504336)

  • 61. Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children.
    Olson SM; Newhams MM; Halasa NB; Feldstein LR; Novak T; Weiss SL; Coates BM; Schuster JE; Schwarz AJ; Maddux AB; Hall MW; Nofziger RA; Flori HR; Gertz SJ; Kong M; Sanders RC; Irby K; Hume JR; Cullimore ML; Shein SL; Thomas NJ; Stewart LS; Barnes JR; Patel MM; Randolph AG;
    Clin Infect Dis; 2022 Aug; 75(2):230-238. PubMed ID: 35024795
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.
    Grijalva CG; Feldstein LR; Talbot HK; Aboodi M; Baughman AH; Brown SM; Casey JD; Erickson HL; Exline MC; Files DC; Gibbs KW; Ginde AA; Gong MN; Halasa N; Khan A; Lindsell CJ; Nwosu SK; Peltan ID; Prekker ME; Rice TW; Shapiro NI; Steingrub JS; Stubblefield WB; Tenforde MW; Patel MM; Self WH;
    Clin Infect Dis; 2021 Oct; 73(8):1459-1468. PubMed ID: 34014274
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A late sharp increase in influenza detections and low interim vaccine effectiveness against the circulating A(H3N2) strain, Denmark, 2021/22 influenza season up to 25 March 2022.
    Emborg HD; Vestergaard LS; Botnen AB; Nielsen J; Krause TG; Trebbien R
    Euro Surveill; 2022 Apr; 27(15):. PubMed ID: 35426361
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
    Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
    Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN).
    Skowronski DM; Zhan Y; Kaweski SE; Sabaiduc S; Khalid A; Olsha R; Carazo S; Dickinson JA; Mather RG; Charest H; Jassem AN; Levade I; Hasso M; Zelyas N; Gao R; Bastien N
    Euro Surveill; 2024 Feb; 29(7):. PubMed ID: 38362622
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016-2017 Season: Insights Into Novel Age-Specific Analysis.
    Stein Y; Mandelboim M; Sefty H; Pando R; Mendelson E; Shohat T; Glatman-Freedman A;
    Clin Infect Dis; 2018 Apr; 66(9):1383-1391. PubMed ID: 29145568
    [TBL] [Abstract][Full Text] [Related]  

  • 67. On field vaccine effectiveness in three periods of 2018/2019 influenza season in Emilia-Romagna Region.
    Colucci ME; Veronesi L; Bracchi MT; Zoni R; Caruso L; Capobianco E; Rossi D; Bizzarro A; Cantarelli A; Affanni P
    Acta Biomed; 2019 Sep; 90(9-S):21-27. PubMed ID: 31517886
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.
    Belongia EA; Simpson MD; King JP; Sundaram ME; Kelley NS; Osterholm MT; McLean HQ
    Lancet Infect Dis; 2016 Aug; 16(8):942-51. PubMed ID: 27061888
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Pozo F; Casado I; Guevara M; Martínez-Baz I; Barricarte A; Ezpeleta C; ;
    Vaccine; 2016 Mar; 34(11):1350-7. PubMed ID: 26854911
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of seasonal influenza vaccine on medically-attended influenza and non-influenza respiratory viruses infections at primary care level, Hong Kong SAR, 2017/18 to 2019/20.
    Chan YW; Wong ML; Kwok FY; Au AK; Leung EC; Chuang SK
    Vaccine; 2021 Jun; 39(25):3372-3378. PubMed ID: 34016472
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Repeated Vaccination Does Not Appear to Impact Upon Influenza Vaccine Effectiveness Against Hospitalization With Confirmed Influenza.
    Cheng AC; Macartney KK; Waterer GW; Kotsimbos T; Kelly PM; Blyth CC;
    Clin Infect Dis; 2017 Jun; 64(11):1564-1572. PubMed ID: 28329167
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influenza vaccine effectiveness estimates against influenza A(H3N2) and A(H1N1) pdm09 among children during school-based outbreaks in the 2016-2017 season in Beijing, China.
    Zhang L; van der Hoek W; Krafft T; Pilot E; Asten LV; Lin G; Wu S; Duan W; Yang P; Wang Q
    Hum Vaccin Immunother; 2020 Apr; 16(4):816-822. PubMed ID: 31596661
    [No Abstract]   [Full Text] [Related]  

  • 74. The impact of repeated vaccination using 10-year vaccination history on protection against influenza in older adults: a test-negative design study across the 2010/11 to 2015/16 influenza seasons in Ontario, Canada.
    Kwong JC; Chung H; Jung JK; Buchan SA; Campigotto A; Campitelli MA; Crowcroft NS; Gubbay JB; Karnauchow T; Katz K; McGeer AJ; McNally JD; Richardson DC; Richardson SE; Rosella LC; Schwartz KL; Simor A; Smieja M; Zahariadis G;
    Euro Surveill; 2020 Jan; 25(1):. PubMed ID: 31937397
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.
    Rose AMC; Kissling E; Gherasim A; Casado I; Bella A; Launay O; Lazăr M; Marbus S; Kuliese M; Syrjänen R; Machado A; Kurečić Filipović S; Larrauri A; Castilla J; Alfonsi V; Galtier F; Ivanciuc A; Meijer A; Mickiene A; Ikonen N; Gómez V; Lovrić Makarić Z; Moren A; Valenciano M;
    Influenza Other Respir Viruses; 2020 May; 14(3):302-310. PubMed ID: 32022450
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
    Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
    Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia.
    Carville KS; Grant KA; Sullivan SG; Fielding JE; Lane CR; Franklin L; Druce J; Kelly HA
    Vaccine; 2015 Jan; 33(2):341-5. PubMed ID: 25448093
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic.
    Okoli GN; Racovitan F; Abdulwahid T; Righolt CH; Mahmud SM
    Vaccine; 2021 Feb; 39(8):1225-1240. PubMed ID: 33494964
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.
    Grohskopf LA; Blanton LH; Ferdinands JM; Chung JR; Broder KR; Talbot HK; Morgan RL; Fry AM
    MMWR Recomm Rep; 2022 Aug; 71(1):1-28. PubMed ID: 36006864
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection.
    Domnich A; Orsi A; Signori A; Chironna M; Manini I; Napoli C; Rizzo C; Panatto D; Icardi G
    Expert Rev Vaccines; 2024; 23(1):380-388. PubMed ID: 38494919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.